Moderna (MRNA.US) stock is up nearly 9% ahead of Wall Street's open today after the company's CEO and a board member bought a combined $6 million worth of shares. Moderna's stock is down about 27% since the beginning of the year, so the insider update is improving investor sentiment around the company.
Nominally, the latest purchases were among the largest in many years. Source: Bloomberg Financial LP
The company's stock is gaining ahead of Wall Street's open, but that doesn't change the fact that the stock is still in a strong downtrend. However, the purchases by people closely associated with the company are certainly improving investor sentiment. Source: xStation
US focus: three things to watch this week
The Week Ahead
Daily summary: Sentiments on Wall Street stall at the end of the week🗽US Dollar gains
AbbVie near 1-month low after earnings report 📉
This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.
